ClinicalTrials.gg
RecruitingNCT05984069FICUFUpdated Mar 18, 2025

Impact of Frailty and ICU-AW on Post-ICU Fatigue Self-reported

An observational study in Post Intensive Care Syndrome, sponsored by Centre Hospitalier Universitaire de Saint Etienne. Recruiting at 2 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-03-18.

Sponsored by Centre Hospitalier Universitaire de Saint Etienne · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 11 months ago, but the record still lists the study as recruiting.
  • Started Jul 2022; still recruiting 4 years 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
150
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 11 studies in postintensive care syndrome with a site in France — 6 open to participants now, 6 under way, none of them phase 3. postintensive care syndrome · France.

Started
2022
with 2 others
Observational
9 of 11
4 open now
Registered
8th of 11
by date
Lead sponsor
1 of 11
Centre Hospitalier Universitaire de Saint Etienne

Among the 11 studies in postintensive care syndrome with a site in France, this one is one of 3 that started in 2022, is one of 9 observational ones, and was the 8th registered.

postintensive care syndrome

106 studies on the registry are indexed under postintensive care syndrome; 49 are open to participants now.

Browse postintensive care syndrome studies →

Open to participants now

6 of the 11 studies in postintensive care syndrome with a site in France are open now. Recruiting first, the newest first:

All 6 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 30 postintensive care syndrome studies recruiting now, 21 (70%) set no upper age limit and 7 (23%) stop at 75 or younger; 4 take children under 18; 2 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in postintensive care syndrome with a site in France, or all of them as a file.
02

Study summary

After a prolonged stay in Intensive Care Unit (ICU), fatigue is the most common symptom reported by patients in the Post Intensive Care Syndrome (PICS). Other complications have been described, including ICU-acquired weakness, leading to increased morbidity and mortality after discharge. Actually, risk factors associated with post-ICU fatigue self-reported are not really known.

Read the detailed description

Frailty, defined as a decrease in physiological reserves leading to an alteration in the mechanisms of adaptation to stress, increases the incidence of PICS and could therefore be a cause of post-ICU fatigue self-reported.

The aim of this study is to identify a relationship between markers of frailty, ICU-AW, ICU story and the post-ICU fatigue self-reported 6 months discharge in patients with prolonged ICU stays.

03

Conditions studied

  • Post Intensive Care Syndrome

Keywords

  • Intensive Care Unit
  • frailty
  • fatigue
  • ICU acquired-weakness
  • FACIT-F
  • physical activity
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients admitted to intensive care, all etiologies combined, excluding immediate post-operative scheduled surgery, with mechanical ventilation for more than 5 days or length of stay in ICU over 10 days.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with a length of stay in intensive care > or equal to 7 days, or mechanical ventilation > or equal to 5 days

Exclusion criteria

Exclusion Criteria:

  • Scheduled surgery with admission in ICU
  • Pregnancy
  • Guardianship
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
150 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients on etiologies

    Patients over 18 admitted in ICU for all etiologies with mechanical ventilation over 5 days or length of stay in ICU over 10 days will be included

    Other: observational prospective data collection

Interventions

  • Otherobservational prospective data collection

    Collection of data from medical records.

06

What researchers measure

Primary outcomes

  1. Frailty

    Relationship between frailty markers (CFS, IADL, sarcopenia and myosteatosis), ICU-AW, ICU story and post-ICU fatigue self-reported

    Time frame: 1 year

Secondary outcomes

  1. Fatigue

    Prevalence of post-ICU fatigue self-reported 6 months discharge in prospective cohort

    Time frame: 1 year

  2. ICU-acquired weakness and fatigue

    Correlation between post-ICU fatigue self-reported and muscular strength assessed by handgrip test

    Time frame: 1 year

  3. Fatigue, quality of life, anxiety and depressive disorder

    Correlation between fatigue, quality of life, anxiety and depressive disorder

    Time frame: 1 year

  4. Kinetic of muscle mass loss and post-ICU fatigue self-reported

    Correlation between the kinetic of muscle mass loss and post-ICU fatigue self-reported

    Time frame: 1 year

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2022 (actual). Primary completion is estimated for Dec 2025, 41 months after the start.

Of 38 observational studies under postintensive care syndrome, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 50. This study's planned 41 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 2, 2023
First posted
Aug 9, 2023
StartActual
Jul 1, 2022
Primary completionEst.
Dec 2025
CompletionEst.
Dec 2025
Last update
Mar 18, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05984069
Responsible party
Sponsor
First posted
Aug 9, 2023
Start date
Jul 1, 2022
Primary completion
Dec 2025 (estimated)
Completion
Dec 2025 (estimated)
Last update
Mar 18, 2025

Study contacts

Jérôme MOREL, MD PhD
Contact
jerome.morel@chu-st-etienne.fr
(0)477828553 ext. +33
Nory ELHADJENE, MD
Contact
nory.saint-etienne@wanadoo.fr
(0)477828553 ext. +33
Jérôme MOREL, MD PhD
principal investigator · CHU Saint Etienne

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion